Capabilities of telemedicine during a pandemic: Part II

September 12, 2020

Ranya Habash, MD, medical director, Technology Innovation, Bascom Palmer Eye Institute, University of Miami, speaks on what she wished she’d known about telemedicine in ophthalmology five years ago, the impact of the pandemic in regards to FDA regulations, as well as why the future of telemedicine requires a new way of thinking.

Ranya Habash, MD, medical director, Technology Innovation, Bascom Palmer Eye Institute, University of Miami, speaks with Ophthalmology Times®' Sheryl Stevenson on what she wished she’d known about telemedicine in ophthalmology five years ago, the impact of the pandemic in regards to FDA regulations and how it’s helped to pave the way forward / expand telemedicine, as well as why the future of telemedicine requires a new way of thinking.

Watch the first interview with Dr. Habash